Skip to main content
Top
Published in: BMC Ophthalmology 1/2012

Open Access 01-12-2012 | Research article

Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease

Authors: Evangelia E Tsironi, Anna Dastiridou, Andreas Katsanos, Efthymios Dardiotis, Stella Veliki, Gianna Patramani, Fani Zacharaki, Stella Ralli, Georgios M Hadjigeorgiou

Published in: BMC Ophthalmology | Issue 1/2012

Login to get access

Abstract

Background

Visual dysfunction is common in Parkinson’s disease (PD). It remains, however, unknown whether it is related to structural alterations of the retina. The aim of this study is to compare visual field (VF) findings and circumpapillary retinal nerve fiber layer (RNFL) thickness in a series of PD patients and normal controls, in order to assess possible retinal anatomical changes and/or functional damage associated with PD.

Methods

PD patients and controls were recruited and underwent VF testing with static automated perimetry and RNFL examination with optical coherence tomography (OCT). Cognitive performance using Mini Mental State Examination (MMSE), PD staging using modified Hoehn and Yahr (H-Y) scale and duration of the disease was recorded in PD patients.

Results

One randomly selected eye from each of 24 patients and 24 age-matched controls was included. OCT RNFL thickness analysis revealed no difference in the inferior, superior, nasal or temporal sectors between the groups. The average peripapillary RNFL was also similar in the two groups. However, perimetric indices of generalized sensitivity loss (mean deviation) and localized scotomas (pattern standard deviation) were worse in patients with PD compared to controls (p < 0.01). 73% of eyes of PD patients had glaucomatous-like asymmetrical hemifield defects with abnormal Glaucoma Hemifield Test and various combinations of arcuate defects (n = 12), nasal steps (n = 11) and paracentral scotomas (n = 16). Bilateral defects were found in 14 patients (58%). No correlation was found between VF indices and MMSE or H-Y scores.

Conclusion

PD patients may demonstrate glaucomatous-like perimetric defects even in the absence of decreased RNFL thickness.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chaudhuri KR, Schapira AH: Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009, 8: 464-474. 10.1016/S1474-4422(09)70068-7.CrossRefPubMed Chaudhuri KR, Schapira AH: Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009, 8: 464-474. 10.1016/S1474-4422(09)70068-7.CrossRefPubMed
2.
go back to reference Jones RD, Donaldson IM, Timmings PL: Impairment of high-contrast visual acuity in Parkinson's disease. Mov Disord. 1992, 7: 232-238. 10.1002/mds.870070308.CrossRefPubMed Jones RD, Donaldson IM, Timmings PL: Impairment of high-contrast visual acuity in Parkinson's disease. Mov Disord. 1992, 7: 232-238. 10.1002/mds.870070308.CrossRefPubMed
3.
go back to reference Silva MF, Faria P, Regateiro FS, Forjaz V, Januário C, Freire A, et al: Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease. Brain. 2005, 128: 2260-2271. 10.1093/brain/awh581.CrossRefPubMed Silva MF, Faria P, Regateiro FS, Forjaz V, Januário C, Freire A, et al: Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease. Brain. 2005, 128: 2260-2271. 10.1093/brain/awh581.CrossRefPubMed
4.
go back to reference Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M: Visual dysfunction in Parkinson's disease Loss in spatiotemporal contrast sensitivity. Brain. 1987, 110: 1675-1698. 10.1093/brain/110.6.1675.CrossRefPubMed Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M: Visual dysfunction in Parkinson's disease Loss in spatiotemporal contrast sensitivity. Brain. 1987, 110: 1675-1698. 10.1093/brain/110.6.1675.CrossRefPubMed
6.
go back to reference Archibald NK, Clarke MP, Mosimann UP, Burn DJ: The retina in Parkinson's disease. Brain. 2009, 132: 1128-1145. 10.1093/brain/awp068.CrossRefPubMed Archibald NK, Clarke MP, Mosimann UP, Burn DJ: The retina in Parkinson's disease. Brain. 2009, 132: 1128-1145. 10.1093/brain/awp068.CrossRefPubMed
8.
go back to reference Nguyen-Legros J: Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg Radiol Anat. 1988, 10: 137-144. 10.1007/BF02307822.CrossRefPubMed Nguyen-Legros J: Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease. Surg Radiol Anat. 1988, 10: 137-144. 10.1007/BF02307822.CrossRefPubMed
9.
go back to reference Harnois C, Di Paolo T: Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci. 1990, 31: 2473-2475.PubMed Harnois C, Di Paolo T: Decreased dopamine in the retinas of patients with Parkinson's disease. Invest Ophthalmol Vis Sci. 1990, 31: 2473-2475.PubMed
10.
go back to reference Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A: Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 2004, 44: 2793-2797. 10.1016/j.visres.2004.06.009.CrossRefPubMed Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A: Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 2004, 44: 2793-2797. 10.1016/j.visres.2004.06.009.CrossRefPubMed
11.
go back to reference Altintas O, Işeri P, Ozkan B, Cağlar Y: Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol. 2008, 116: 137-146. 10.1007/s10633-007-9091-8.CrossRefPubMed Altintas O, Işeri P, Ozkan B, Cağlar Y: Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol. 2008, 116: 137-146. 10.1007/s10633-007-9091-8.CrossRefPubMed
12.
go back to reference Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, et al: Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol. 2011, 21: 24-29. 10.5301/EJO.2010.1318.CrossRefPubMed Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, et al: Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol. 2011, 21: 24-29. 10.5301/EJO.2010.1318.CrossRefPubMed
13.
go back to reference Swanson EA, Izatt JA, Hee MR, Huang D, Lin CP, Schuman JS, et al: In vivo retinal imaging by optical coherence tomography. Opt Lett. 1993, 18: 1864-1866. 10.1364/OL.18.001864.CrossRefPubMed Swanson EA, Izatt JA, Hee MR, Huang D, Lin CP, Schuman JS, et al: In vivo retinal imaging by optical coherence tomography. Opt Lett. 1993, 18: 1864-1866. 10.1364/OL.18.001864.CrossRefPubMed
14.
go back to reference Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S: Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol. 2010, 4: 1427-1432.PubMedPubMedCentral Aaker GD, Myung JS, Ehrlich JR, Mohammed M, Henchcliffe C, Kiss S: Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin Ophthalmol. 2010, 4: 1427-1432.PubMedPubMedCentral
15.
go back to reference Archibald NK, Clarke MP, Mosimann UP, Burn DJ: Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord. 2011, 17: 431-436. 10.1016/j.parkreldis.2011.03.004.CrossRefPubMed Archibald NK, Clarke MP, Mosimann UP, Burn DJ: Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord. 2011, 17: 431-436. 10.1016/j.parkreldis.2011.03.004.CrossRefPubMed
16.
go back to reference Albrecht P, Müller AK, Südmeyer M, Ferrea S, Ringelstein M, Cohn E, et al: Optical coherence tomography in parkinsonian syndromes. PLoS One. 2012, 7 (4): 34891-10.1371/journal.pone.0034891. Epub 2012 Apr 13CrossRef Albrecht P, Müller AK, Südmeyer M, Ferrea S, Ringelstein M, Cohn E, et al: Optical coherence tomography in parkinsonian syndromes. PLoS One. 2012, 7 (4): 34891-10.1371/journal.pone.0034891. Epub 2012 Apr 13CrossRef
17.
go back to reference Yenice O, Onal S, Midi I, Ozcan E, Temel A, I-Gunal D: Visual field analysis in patients with Parkinson's disease. Parkinsonism Relat Disord. 2008, 14: 193-198. 10.1016/j.parkreldis.2007.07.018.CrossRefPubMed Yenice O, Onal S, Midi I, Ozcan E, Temel A, I-Gunal D: Visual field analysis in patients with Parkinson's disease. Parkinsonism Relat Disord. 2008, 14: 193-198. 10.1016/j.parkreldis.2007.07.018.CrossRefPubMed
18.
go back to reference Gelb DJ, Oliver E, Gilman S: Diagnostic criteria for Parkinson disease. Arch Neurol. 1999, 56: 33-39. 10.1001/archneur.56.1.33.CrossRefPubMed Gelb DJ, Oliver E, Gilman S: Diagnostic criteria for Parkinson disease. Arch Neurol. 1999, 56: 33-39. 10.1001/archneur.56.1.33.CrossRefPubMed
19.
go back to reference Goldberg I, Graham SL, Klistorner AI: Multifocal objective perimetry in the detection of glaucomatous field loss. Am J Ophthalmol. 2002, 133: 29-39. 10.1016/S0002-9394(01)01294-6.CrossRefPubMed Goldberg I, Graham SL, Klistorner AI: Multifocal objective perimetry in the detection of glaucomatous field loss. Am J Ophthalmol. 2002, 133: 29-39. 10.1016/S0002-9394(01)01294-6.CrossRefPubMed
20.
21.
go back to reference Yavas GF, Yilmaz O, Küsbeci T, Oztürk F: The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. Eur J Ophthalmol. 2007, 17: 812-816.PubMed Yavas GF, Yilmaz O, Küsbeci T, Oztürk F: The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. Eur J Ophthalmol. 2007, 17: 812-816.PubMed
22.
go back to reference Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, et al: Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol. 2009, 127: 737-741. 10.1001/archophthalmol.2009.106.CrossRefPubMed Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, et al: Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol. 2009, 127: 737-741. 10.1001/archophthalmol.2009.106.CrossRefPubMed
23.
go back to reference Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al: Optical coherence tomography. Science. 1991, 254: 1178-1181. 10.1126/science.1957169.CrossRefPubMedPubMedCentral Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al: Optical coherence tomography. Science. 1991, 254: 1178-1181. 10.1126/science.1957169.CrossRefPubMedPubMedCentral
24.
go back to reference Sung KR, Kim JS, Wollstein G, Folio L, Kook MS, Schuman JS: Imaging of the retinal nerve fibre layer with spectral domain optical coherence tomography for glaucoma diagnosis. Br J Ophthalmol. 2011, 95: 909-914. 10.1136/bjo.2010.186924.CrossRefPubMed Sung KR, Kim JS, Wollstein G, Folio L, Kook MS, Schuman JS: Imaging of the retinal nerve fibre layer with spectral domain optical coherence tomography for glaucoma diagnosis. Br J Ophthalmol. 2011, 95: 909-914. 10.1136/bjo.2010.186924.CrossRefPubMed
25.
go back to reference Wojtkowski M, Srinivasan V, Fujimoto JG, Ko T, Schuman JS, Kowalczyk A, et al: Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2005, 112: 1734-1746. 10.1016/j.ophtha.2005.05.023.CrossRefPubMedPubMedCentral Wojtkowski M, Srinivasan V, Fujimoto JG, Ko T, Schuman JS, Kowalczyk A, et al: Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2005, 112: 1734-1746. 10.1016/j.ophtha.2005.05.023.CrossRefPubMedPubMedCentral
26.
go back to reference Nassif N, Cense B, Park BH, Yun SH, Chen TC, Bouma BE, et al: In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett. 2004, 29: 480-482. 10.1364/OL.29.000480.CrossRefPubMed Nassif N, Cense B, Park BH, Yun SH, Chen TC, Bouma BE, et al: In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett. 2004, 29: 480-482. 10.1364/OL.29.000480.CrossRefPubMed
27.
go back to reference Sehi M, Grewal DS, Sheets CW, Greenfield DS: Diagnostic ability of Fourier-domain vs time-domain optical coherence tomography for glaucoma detection. Am J Ophthalmol. 2009, 148: 597-605. 10.1016/j.ajo.2009.05.030.CrossRefPubMedPubMedCentral Sehi M, Grewal DS, Sheets CW, Greenfield DS: Diagnostic ability of Fourier-domain vs time-domain optical coherence tomography for glaucoma detection. Am J Ophthalmol. 2009, 148: 597-605. 10.1016/j.ajo.2009.05.030.CrossRefPubMedPubMedCentral
28.
go back to reference Chang RT, Knight OJ, Feuer WJ, Budenz DL: Sensitivity and specificity of time-domain versus spectral-domain optical coherence tomography in diagnosing early to moderate glaucoma. Ophthalmology. 2009, 116: 2294-2299. 10.1016/j.ophtha.2009.06.012.CrossRefPubMed Chang RT, Knight OJ, Feuer WJ, Budenz DL: Sensitivity and specificity of time-domain versus spectral-domain optical coherence tomography in diagnosing early to moderate glaucoma. Ophthalmology. 2009, 116: 2294-2299. 10.1016/j.ophtha.2009.06.012.CrossRefPubMed
29.
go back to reference Moreno-Montanes J, Olmo N, Alvarez A, Garcia N, Zarranz-Ventura J: Cirrus high-definition optical coherence tomography compared with Stratus optical coherence tomography in glaucoma diagnosis. Invest Ophthalmol Vis Sci. 2010, 51: 335-343. 10.1167/iovs.08-2988.CrossRefPubMed Moreno-Montanes J, Olmo N, Alvarez A, Garcia N, Zarranz-Ventura J: Cirrus high-definition optical coherence tomography compared with Stratus optical coherence tomography in glaucoma diagnosis. Invest Ophthalmol Vis Sci. 2010, 51: 335-343. 10.1167/iovs.08-2988.CrossRefPubMed
30.
go back to reference Bayer AU, Keller ON, Ferrari F, Maag KP: Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol. 2002, 133: 135-137. 10.1016/S0002-9394(01)01196-5.CrossRefPubMed Bayer AU, Keller ON, Ferrari F, Maag KP: Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol. 2002, 133: 135-137. 10.1016/S0002-9394(01)01196-5.CrossRefPubMed
31.
go back to reference Bodis-Wollner I: Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci. 1990, 13: 296-302. 10.1016/0166-2236(90)90113-O.CrossRefPubMed Bodis-Wollner I: Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci. 1990, 13: 296-302. 10.1016/0166-2236(90)90113-O.CrossRefPubMed
32.
go back to reference Djamgoz MB, Hankins MW, Hirano J, Archer SN: Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res. 1997, 37: 3509-3529. 10.1016/S0042-6989(97)00129-6.CrossRefPubMed Djamgoz MB, Hankins MW, Hirano J, Archer SN: Neurobiology of retinal dopamine in relation to degenerative states of the tissue. Vision Res. 1997, 37: 3509-3529. 10.1016/S0042-6989(97)00129-6.CrossRefPubMed
33.
go back to reference Peppe A, Stanzione P, Pierelli F, De Angelis D, Pierantozzi M, Bernardi G: Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology. 1995, 45: 1144-1148. 10.1212/WNL.45.6.1144.CrossRefPubMed Peppe A, Stanzione P, Pierelli F, De Angelis D, Pierantozzi M, Bernardi G: Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology. 1995, 45: 1144-1148. 10.1212/WNL.45.6.1144.CrossRefPubMed
34.
go back to reference Gottlob I, Schneider E, Heider W, Skrandies W: Alteration of visual evoked potentials and electroretinograms in Parkinson's disease. Electroencephalogr Clin Neurophysiol. 1987, 66: 349-357. 10.1016/0013-4694(87)90032-0.CrossRefPubMed Gottlob I, Schneider E, Heider W, Skrandies W: Alteration of visual evoked potentials and electroretinograms in Parkinson's disease. Electroencephalogr Clin Neurophysiol. 1987, 66: 349-357. 10.1016/0013-4694(87)90032-0.CrossRefPubMed
35.
go back to reference Langheinrich T, Elst L, Tebartz V, Lagrèze WA, Bach M, Lücking CH, et al: Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol. 2000, 111: 66-74. 10.1016/S1388-2457(99)00223-0.CrossRefPubMed Langheinrich T, Elst L, Tebartz V, Lagrèze WA, Bach M, Lücking CH, et al: Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol. 2000, 111: 66-74. 10.1016/S1388-2457(99)00223-0.CrossRefPubMed
36.
go back to reference Nightingale S, Mitchell KW, Howe JW: Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects. J Neurol Neurosurg Psychiatry. 1986, 49: 1280-1287. 10.1136/jnnp.49.11.1280.CrossRefPubMedPubMedCentral Nightingale S, Mitchell KW, Howe JW: Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects. J Neurol Neurosurg Psychiatry. 1986, 49: 1280-1287. 10.1136/jnnp.49.11.1280.CrossRefPubMedPubMedCentral
37.
go back to reference Bodis-Wollner I, Yahr MD: Measurements of visual evoked potentials in Parkinson's disease. Brain. 1978, 101: 661-671. 10.1093/brain/101.4.661.CrossRefPubMed Bodis-Wollner I, Yahr MD: Measurements of visual evoked potentials in Parkinson's disease. Brain. 1978, 101: 661-671. 10.1093/brain/101.4.661.CrossRefPubMed
38.
go back to reference Shibasaki H, Tsuji S, Kuroiwa Y: Oculomotor abnormalities in Parkinson's disease. Arch Neurol. 1979, 36: 360-364. 10.1001/archneur.1979.00500420070009.CrossRefPubMed Shibasaki H, Tsuji S, Kuroiwa Y: Oculomotor abnormalities in Parkinson's disease. Arch Neurol. 1979, 36: 360-364. 10.1001/archneur.1979.00500420070009.CrossRefPubMed
39.
go back to reference Wild JM, Pacey IE, Hancock SA, Cunliffe IA: Between-algorithm, between-individual differences in normal perimetric sensitivity: full threshold, FASTPAC, and SITA. Swedish Interactive Threshold algorithm. Invest Ophthalmol Vis Sci. 1999, 40: 1152-1161.PubMed Wild JM, Pacey IE, Hancock SA, Cunliffe IA: Between-algorithm, between-individual differences in normal perimetric sensitivity: full threshold, FASTPAC, and SITA. Swedish Interactive Threshold algorithm. Invest Ophthalmol Vis Sci. 1999, 40: 1152-1161.PubMed
40.
go back to reference Bengtsson B, Olsson J, Heijl A, Rootzén H: A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmol Scand. 1997, 75: 368-375.CrossRefPubMed Bengtsson B, Olsson J, Heijl A, Rootzén H: A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmol Scand. 1997, 75: 368-375.CrossRefPubMed
41.
go back to reference Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, et al: The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010, 9 (75): 1717-1725.CrossRef Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, et al: The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology. 2010, 9 (75): 1717-1725.CrossRef
Metadata
Title
Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease
Authors
Evangelia E Tsironi
Anna Dastiridou
Andreas Katsanos
Efthymios Dardiotis
Stella Veliki
Gianna Patramani
Fani Zacharaki
Stella Ralli
Georgios M Hadjigeorgiou
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2012
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/1471-2415-12-54

Other articles of this Issue 1/2012

BMC Ophthalmology 1/2012 Go to the issue